HUMAN INSULIN and FATIGUE

Overview

FATIGUE is the #8 most commonly reported adverse reaction for HUMAN INSULIN, manufactured by Novo Nordisk. There are 452 FDA adverse event reports linking HUMAN INSULIN to FATIGUE. This represents approximately 1.9% of all 24,125 adverse event reports for this drug.

Patients taking HUMAN INSULIN who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

FATIGUE is a less commonly reported adverse event for HUMAN INSULIN, but still significant enough to appear in the safety profile.

Other Side Effects of HUMAN INSULIN

In addition to fatigue, the following adverse reactions have been reported for HUMAN INSULIN:

• BLOOD GLUCOSE INCREASED — 2,004 reports
• BLOOD GLUCOSE DECREASED — 717 reports
• NAUSEA — 681 reports
• DRUG INEFFECTIVE — 628 reports
• DIARRHOEA — 502 reports
• DYSPNOEA — 500 reports
• DIZZINESS — 459 reports
• HYPOGLYCAEMIA — 445 reports
• MALAISE — 388 reports
• FALL — 386 reports

Other Drugs Associated with FATIGUE

The following drugs have also been linked to fatigue in FDA adverse event reports:

Does HUMAN INSULIN cause FATIGUE?

FATIGUE has been reported as an adverse event in 452 FDA reports for HUMAN INSULIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is FATIGUE with HUMAN INSULIN?

FATIGUE accounts for approximately 1.9% of all adverse event reports for HUMAN INSULIN, making it a notable side effect.

What should I do if I experience FATIGUE while taking HUMAN INSULIN?

If you experience fatigue while taking HUMAN INSULIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages